Church & Dwight Co., Inc. CHD SPX
Company Overview
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers baking soda, cat litters, laundry detergents, carpet deodorizers, and other baking soda-based products under the ARM & HAMMER brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; dry shampoos under the BATISTE brand; water flossers under the WATERPIK brand; oral care products under the THERABREATH brand; acne treatment products under the HERO brand; hand sanitizers under the TOUCHLAND brand; and condoms, lubricants, and vibrators under the TROJAN brand. It also provides home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; and cold shortening and relief products under the ZICAM brand. In addition, the company's specialty products include animal and food productivity products, such as ARM & HAMMER baking soda as a feed additive to help dairy cow; BIO-CHLOR and FERMENTEN used to reduce health issues associated with calving, as well as needed protein; CELMANAX refined functional carbohydrate, a yeast-based prebiotic; and CERTILLUS a probiotics products used in the poultry, dairy, beef, and swine industries. Additionally, it offers sodium bicarbonate; and cleaning and deodorizing products. The company sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. Church & Dwight Co., Inc. was founded in 1846 and is headquartered in Ewing, New Jersey.
Why Investors Should Care
Generates a return on equity of 16.8%, reflecting efficient use of shareholder capital.
Operating margin of 20.2% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $6.20B (+1.6% YoY); net profit $736.80M.
- Trailing 12 Months Year-on-year growth — revenue +0.2%, earnings +2.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 5.7%, profit CAGR 8.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 5.69% |
| 1 Year: | 0.20% |
Compounded Profit Growth
| 5 Years: | 8.13% |
| 1 Year: | 2.20% |
Stock Price Performance
| 1 Year: | +1.38% |
| 6 Months: | +12.81% |
| 3 Months: | +2.02% |
| 1 Month: | -0.43% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)50.93 · Neutral
P/E of 32.49 is above the sector median of 20.61 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CHD Church & Dwight Co., Inc. SPX | 97.14 | 32.49 | $23.02B | 1.27% | 14.53% | 16.78% | 5.69% | 8.13% |
| 2 | WMT Walmart Inc. SPX | 112.53 | 39.62 | $895.52B | 0.89% | 18.21% | 24.13% | 5.27% | 23.30% |
| 3 | COST Costco Wholesale Corporation NDXSPX | 916.54 | 46.24 | $406.47B | 0.63% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPX | 82.45 | 25.93 | $354.74B | 2.52% | 16.47% | 43.37% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPX | 148.05 | 21.64 | $344.75B | 2.92% | 22.93% | 31.11% | 0.36% | 1.66% |
| 6 | PM Philip Morris International Inc. SPX | 180.88 | 25.44 | $281.91B | 3.34% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPX | 135.40 | 17.75 | $184.96B | 4.37% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | MO Altria Group, Inc. SPX | 70.52 | 14.72 | $117.76B | 6.04% | 38.27% | - | 1.24% | -1.89% |
| 9 | MNST Monster Beverage Corporation NDXSPX | 97.57 | 47.14 | $95.42B | 0.00% | 28.33% | 26.65% | 13.03% | 14.82% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | 877.20M | 898.00M | 967.90M | 1.03B | 1.01B | 1.03B | 1.04B | 1.07B | 1.04B | 1.08B | 1.09B | 1.14B | 1.17B | 1.19B | 1.24B | 1.30B | 1.24B | 1.27B | 1.31B | 1.30B | 1.33B | 1.32B | 1.43B | 1.45B | 1.46B | 1.50B | 1.51B | - | - | 1.47B | 1.51B | 1.59B | 1.64B | 1.47B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 807.50M | 859.30M | 871.20M | 890.40M | 787.90M |
| Gross Profit | 385.80M | 397.40M | 379.00M | 408.00M | 395.60M | 408.00M | 399.30M | 410.40M | 438.50M | 481.40M | 451.50M | 454.90M | 460.10M | 474.30M | 470.80M | 481.50M | 507.70M | 524.00M | 532.00M | 559.60M | 565.20M | 557.40M | 550.90M | 552.20M | 579.20M | 552.50M | 545.30M | 549.70M | 622.00M | 638.90M | 646.30M | 687.00M | 712.10M | - | - | 659.60M | 647.00M | 714.40M | 753.80M | 681.40M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 364.30M | 385.30M | 459.80M | 487.80M | 390.40M |
| Operating Income | 190.60M | 169.20M | 179.50M | 175.30M | 196.00M | 173.40M | 196.10M | 123.20M | 198.70M | 214.70M | 220.30M | 173.80M | 204.20M | 193.40M | 240.80M | 187.40M | 216.80M | 195.20M | 314.60M | 250.70M | 273.80M | 190.60M | 302.60M | 298.70M | 301.40M | 280.70M | 261.60M | 253.90M | 291.90M | 293.60M | 255.80M | 305.00M | 336.90M | - | - | 295.30M | 261.70M | 254.60M | 266.00M | 291.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 366.30M | 330.60M | 324.10M | 278.50M | 359.50M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 23.30M | 23.50M | 23.80M | 24.60M | 24.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 282.10M | 250.50M | 236.20M | 188.10M | 272.60M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 62.00M | 59.50M | 54.00M | 44.60M | 56.30M |
| Net Income | 120.40M | 109.10M | 113.00M | 111.60M | 124.00M | 110.40M | - | - | - | - | 157.80M | 121.70M | 146.30M | - | 175.70M | 138.50M | 157.30M | - | 229.80M | 189.70M | 216.20M | - | 220.70M | 218.30M | 230.40M | 204.40M | 187.10M | 187.10M | 203.20M | 221.20M | 177.50M | 227.70M | 243.50M | - | - | 220.10M | 191.00M | 182.20M | 143.50M | 216.30M |
| Diluted EPS | 0.45 | 0.41 | 0.43 | 0.43 | 0.47 | 0.42 | 0.51 | 0.29 | 0.52 | 1.60 | 0.63 | 0.49 | 0.58 | 0.57 | 0.70 | 0.55 | 0.62 | 0.58 | 0.92 | 0.75 | 0.85 | 0.59 | 0.88 | 0.87 | 0.92 | 0.83 | 0.76 | 0.76 | 0.82 | 0.89 | 0.71 | 0.93 | 0.99 | - | - | 0.89 | 0.78 | 0.75 | 0.60 | 0.91 |
| R&D Expense | 16.00M | - | 14.40M | 16.10M | 14.50M | - | 14.10M | 16.00M | 18.00M | - | 19.50M | 21.80M | 23.10M | - | 20.70M | 22.40M | 24.50M | - | 21.70M | 24.60M | 27.00M | - | 24.10M | 25.40M | 27.70M | 24.50M | 27.20M | 29.20M | 26.70M | 30.20M | 30.30M | 30.10M | 33.00M | 36.00M | - | 32.80M | 35.80M | 36.20M | - | 31.60M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.42B | 2.52B | 2.59B | 2.75B | 2.92B | 3.19B | 3.30B | 3.39B | 3.49B | 3.78B | 4.15B | 4.36B | 4.90B | 5.19B | 5.38B | 5.87B | 6.11B | 6.20B |
| Gross Profit | 971.72M | 1.10B | 1.16B | 1.21B | 1.29B | 1.44B | 1.45B | 1.51B | 1.59B | 1.73B | 1.84B | 1.98B | 2.21B | 2.26B | 2.25B | 2.59B | 2.79B | 2.77B |
| Operating Income | 340.33M | 412.90M | 445.00M | 492.60M | 545.10M | 622.20M | 641.20M | 674.20M | 724.20M | 732.70M | 791.70M | 840.20M | 1.03B | 1.08B | 597.80M | 1.06B | 807.10M | 1.08B |
| Net Income | 195.17M | 243.50M | 270.70M | 309.60M | 349.80M | 394.40M | 413.90M | 410.40M | 459.00M | 743.40M | 568.60M | 615.90M | 785.90M | 827.50M | 413.90M | 755.60M | 585.30M | 736.80M |
| Diluted EPS | 2.78 | 1.70 | 1.87 | 2.12 | 2.45 | 2.79 | 1.51 | 1.54 | 1.75 | 2.90 | 2.27 | 2.44 | 3.12 | 3.32 | 1.68 | 3.05 | 2.37 | 3.02 |
| R&D Expense | - | 55.10M | 53.70M | 55.10M | 54.80M | 61.80M | 59.80M | 64.70M | 63.20M | 70.80M | 89.70M | 93.60M | 102.60M | 105.20M | 110.00M | 122.40M | 139.70M | 145.60M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 3.12B | 2.95B | 3.12B | 4.10B | 4.24B | 4.36B | 4.26B | 4.35B | 6.01B | 6.07B | 6.66B | 7.41B | 8.00B | 8.35B | 8.57B | 8.88B | 8.91B |
| Total Equity | 1.08B | 1.33B | 1.60B | 1.87B | 2.04B | 2.06B | 2.30B | 2.10B | 2.02B | 1.98B | 2.22B | 2.45B | 2.67B | 3.02B | 3.23B | 3.49B | 3.86B | 4.36B | 4.00B |
| Cash & Equivalents | 249.81M | 198.00M | 447.10M | 189.20M | 251.40M | 343.00M | 496.90M | 423.00M | 330.00M | 187.80M | 278.90M | 316.70M | 155.70M | 183.10M | 240.60M | 270.30M | 344.50M | 964.10M | 409.00M |
| Long Term Debt | - | - | 597.35M | 249.70M | 249.70M | 649.40M | 649.50M | 690.00M | 692.80M | 693.40M | 2.10B | 1.51B | 1.81B | 1.81B | 2.20B | 2.60B | 2.20B | 2.20B | 2.21B |
| Total Liabilities | - | - | 1.52B | 1.07B | 1.08B | 2.04B | 1.96B | 2.26B | 2.23B | 2.38B | 3.80B | 3.62B | 3.99B | 4.39B | 4.76B | 4.86B | 4.71B | 4.52B | 4.91B |
| Current Liabilities | - | - | 567.03M | 447.10M | 383.60M | 725.60M | 651.20M | 905.30M | 872.70M | 1.00B | 935.00M | 1.33B | 1.09B | 1.39B | 2.08B | 1.18B | 1.42B | 1.32B | 1.50B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 336.17M | 400.90M | 428.50M | 437.80M | 523.60M | 499.60M | - | - | 655.30M | 681.50M | 763.60M | 864.50M | 990.30M | 993.80M | 885.20M | 1.03B | 1.16B | 1.22B |
| Investing Cash Flow | -466.16M | -104.10M | -180.40M | -147.80M | -741.30M | -77.10M | - | - | -354.60M | -1.30B | -112.10M | -553.50M | -608.10M | -682.00M | -728.60M | -234.30M | -183.30M | -616.90M |
| Financing Cash Flow | 87.22M | -58.30M | -503.70M | -226.50M | 305.20M | -259.80M | - | - | -439.60M | 698.90M | -609.00M | -472.90M | -360.10M | -252.10M | -120.90M | -725.60M | -343.40M | -1.16B |
| Capital Expenditure | -98.32M | -135.40M | -63.80M | -76.60M | -74.50M | -67.10M | -70.50M | -61.80M | -49.80M | -45.00M | -60.40M | -73.70M | -98.90M | -118.80M | -178.80M | -223.50M | -179.80M | -122.40M |
| Free Cash Flow | 237.85M | 265.50M | 364.70M | 361.20M | 449.10M | 432.50M | - | - | 605.50M | 636.50M | 703.20M | 790.80M | 891.40M | 875.00M | 706.40M | 807.10M | 976.40M | 1.09B |
| Share Buybacks | 403.00K | 400.00K | 100.00K | 80.20M | 250.40M | 50.10M | 478.80M | 363.10M | 400.00M | 400.00M | 200.00M | 250.00M | 300.00M | 500.00M | 0 | 300.10M | 0 | 900.00M |
| Dividends Paid | 23.11M | 32.30M | 44.00M | 97.40M | 134.50M | 155.20M | 167.50M | 175.30M | 183.00M | 190.40M | 213.30M | 224.10M | 237.30M | 247.50M | 255.00M | 266.50M | 277.00M | 287.20M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 40.1% | 43.7% | 44.7% | 44.2% | 44.2% | 45.0% | 44.1% | 44.5% | 45.5% | 45.8% | 44.4% | 45.5% | 45.2% | 43.6% | 41.9% | 44.1% | 45.7% | 44.7% |
| Operating Margin % | 14.0% | 16.4% | 17.2% | 17.9% | 18.7% | 19.5% | 19.4% | 19.9% | 20.7% | 19.4% | 19.1% | 19.3% | 21.0% | 20.8% | 11.1% | 18.0% | 13.2% | 17.4% |
| Net Margin % | 8.1% | 9.7% | 10.5% | 11.3% | 12.0% | 12.3% | 12.6% | 12.1% | 13.1% | 19.7% | 13.7% | 14.1% | 16.1% | 15.9% | 7.7% | 12.9% | 9.6% | 11.9% |
| ROE % | 14.7% | 15.2% | 14.5% | 15.2% | 17.0% | 17.1% | 19.7% | 20.3% | 23.2% | 33.5% | 23.2% | 23.1% | 26.0% | 25.6% | 11.9% | 19.6% | 13.4% | 18.4% |
| ROCE % | - | 16.2% | 17.8% | 18.0% | 16.2% | 17.4% | 18.6% | 19.9% | 21.6% | 14.4% | 16.7% | 15.1% | 17.1% | 18.2% | 8.3% | 14.8% | 10.7% | 14.5% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 9.37% | 22.19M | $2.12B |
| 2 | Vanguard Capital Management LLC | 6.50% | 15.41M | $1.47B |
| 3 | State Street Corporation | 5.91% | 14.00M | $1.34B |
| 4 | Vanguard Portfolio Management LLC | 5.46% | 12.94M | $1.23B |
| 5 | JPMORGAN CHASE & CO | 4.42% | 10.47M | $998.91M |
| 6 | Capital International Investors | 3.09% | 7.32M | $698.36M |
| 7 | Fundsmith LLP | 2.80% | 6.64M | $633.67M |
| 8 | Geode Capital Management, LLC | 2.67% | 6.33M | $603.81M |
| 9 | Allspring Global Investments Holdings, LLC | 2.13% | 5.05M | $481.83M |
| 10 | Morgan Stanley | 2.06% | 4.87M | $464.87M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CHD
Church & Dwight (CHD) Stock Still Looks Pricey Despite Its 16% Five Year Return - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOS3JyQ3dIb05pR2ZEM2hFT1BoVDJIaDljc1RfUktBbTBLdjFBdElPV3NrSGcwbFZIeHZxb3N6dllKaWNaWG9TMGlVb3RKNDR5NEMxbTdQUHFlbm00Mm81T0FPWkNPcWlQbXlNVEFXRnNGMmZXTkVhcTlrZUFiQ01GUmZNRUxiNGZzX2t1eU…
1 Mid-Cap Stock to Keep an Eye On and 2 We Ignore - StockStory
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNNHVGVFY5dzBZbDUwN2lIV3ZMekd2LTJsa29TeG5aR0Fmd0FfdUdkc1NGTEJhTHJJSGozWkVCaFlJcHNvSWJpOWVuYlZxRmRNTGRSd1g0RUxDRFg3OFlZd0dVd0U0MHBsOG04d0hyRWxaSWlkTmswdlN1T3E4Zm1SSG4zOUtoVTFFdlNQaG…
Paradiem LLC Acquires 38,700 Shares of Church & Dwight Co., Inc. $CHD - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOMHJvdVRVdk54cy1KYmUxb3NyUDBpb0g4aE5lV1V5QlRwa2ZYeExPN2Q2dFk3UnZNODNZWFN2U01tRjNuV0ZwOWZQVTJlc01rZi1nSjVDbDVyMHJ2RGNMbFY4emhpbl9tTkNhdVQzX3U4R1lWaHE3Q3ZodzB0V1dmQ3ZlSzdrSDhFd0loRH…
Is Church & Dwight (CHD) Undervalued After Its E Commerce Growth Story? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxOZEhTLWQ1UHkya0FvRHJSNFk3R1d0TW9FNU9VY0Y1OXNFQmlUWEhnMnlZOGlON29Dc21OMG8tdlJQdGEzQlRGdVdBeUM1YVJNQ2tQUUNTRFVCdVpBMUlCdTNFNTNHekMxX0dJMVlYamtuLVhvLU1VMDA1VVRsN05lZEZGSjQ4el8zR2g3YU…
3 Reasons CHD is Risky and 1 Stock to Buy Instead - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxOczBFRkVBZ3p5aTZtUV84Z3BEU0ZNSklObnZ0Y3JJN2lUV1hGMEwzbjg2RFhnZ2JYYVotYVNSLTZCQTR2VWROUVFNWC10RjRsRzM0bnlhakRWcGVBazd0eEM1alpFbm9YdTJOUV80bWdaZ05XVlhYWXRZQTBfU3BpZEVETDRBZUp1cV9MaG…
How Will Church & Dwight Stock React To Its Upcoming Earnings? - Trefis
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQWHljVUZYTDdvVWZUSFdsSDJOZl9DU2g1XzNaVUJib1Z5bnZ3TmE0RE1ZMHl3cFZvZjVjTC1xUS1vZ2F6emFGLVd3b3NtN0liamc0dE9LcDY3WkxUa0ZLMTdCX3VmY2ZDZ2NSWmVaQ3M0Vm81VWtvb1E0NURwRWJLOWs2eE9vaHg2WjNTU2…
CHD — Frequently Asked Questions
What is the current share price of Church & Dwight Co., Inc. (CHD)?
As of 2026-07-15 16:51 PDT, Church & Dwight Co., Inc. (CHD) trades at $97.14 on NYSE. Its 52-week range is $81.00 to $104.92.
What is the market capitalisation of CHD?
Church & Dwight Co., Inc. (CHD) has a market capitalisation of $23.02B on NYSE.
What is the P/E ratio of CHD?
CHD trades at a trailing price-to-earnings (P/E) ratio of 32.49. The industry average P/E is 20.61. Its price-to-book (P/B) ratio is 5.40.
Does CHD pay a dividend?
Church & Dwight Co., Inc. (CHD) currently offers a dividend yield of 1.27%.
What is the return on equity (ROE) of CHD?
CHD has a return on equity (ROE) of 16.78%. Its return on capital employed (ROCE) is 14.53%.
Is CHD a good stock to buy?
This page provides a data-driven analysis of Church & Dwight Co., Inc. (CHD), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.